Rheonix, Inc., based in Ithaca, United States, is a biomedical device company focused on miniaturizing and automating assays across various fields. Their flagship product, the CARD (Chemistry And Reagent Device) system, supports applications in human and veterinary diagnostics, food and water testing, SNP analysis for personalized medicine, homeland security, process control, and tissue culture analysis. Rheonix aims to provide accessible and efficient molecular testing solutions.
Rheonix has achieved significant milestones, including the development of the Encompass family of workstations, which offers fully automated and integrated molecular testing with meaningful multiplexing capabilities. Their collaboration with the FDA/CFSAN on Cyclospora cayetanensis data underscores their impact on public health. Rheonix's products are designed to be open and adaptable, enabling laboratories to develop customized assays and streamline their testing processes.
